PMID- 7595175
OWN - NLM
STAT- MEDLINE
DCOM- 19951213
LR  - 20190904
IS  - 0954-6820 (Print)
IS  - 0954-6820 (Linking)
VI  - 238
IP  - 4
DP  - 1995 Oct
TI  - Dramatic responses to intravenous immunoglobulin in vasculitis.
PG  - 375-7
AB  - Intravenous immunoglobulin (IVIG) has been successfully used to treat autoimmune 
      diseases. We report dramatic, rapid and sustained responses to its use in two 
      cases of vasculitis: a patient with primary angitis of the central nervous 
      system: and a patient with hepatitis-B-antigen-related polyarteritis nodosa, who 
      failed treatment with corticosteroids. Improvement in gait and a marked decrease 
      in serum creatinine, respectively, were observed within 24 h of the first dose of 
      IVIG. Both patients remained stable for several months. We conclude that IVIG 
      should be considered in patients with vasculitis who fail corticosteroids, or 
      when a rapid response is required.
FAU - Boman, S
AU  - Boman S
AD  - Department of Internal Medicine, University of Nevada School of Medicine, Las 
      Vegas, USA.
FAU - Ballen, J L
AU  - Ballen JL
FAU - Seggev, J S
AU  - Seggev JS
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - England
TA  - J Intern Med
JT  - Journal of internal medicine
JID - 8904841
RN  - 0 (Immunoglobulins, Intravenous)
SB  - IM
MH  - Adult
MH  - Female
MH  - Humans
MH  - Immunoglobulins, Intravenous/*therapeutic use
MH  - Male
MH  - Vasculitis/*drug therapy
EDAT- 1995/10/01 00:00
MHDA- 1995/10/01 00:01
CRDT- 1995/10/01 00:00
PHST- 1995/10/01 00:00 [pubmed]
PHST- 1995/10/01 00:01 [medline]
PHST- 1995/10/01 00:00 [entrez]
AID - 10.1111/j.1365-2796.1995.tb01213.x [doi]
PST - ppublish
SO  - J Intern Med. 1995 Oct;238(4):375-7. doi: 10.1111/j.1365-2796.1995.tb01213.x.